These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Peptidylarginine Deiminase 4 Promotes the Renal Infiltration of Neutrophils and Exacerbates the TLR7 Agonist-Induced Lupus Mice. Hanata N; Shoda H; Hatano H; Nagafuchi Y; Komai T; Okamura T; Suzuki A; Gunarta IK; Yoshioka K; Yamamoto K; Fujio K Front Immunol; 2020; 11():1095. PubMed ID: 32655553 [TBL] [Abstract][Full Text] [Related]
3. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation. Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029 [TBL] [Abstract][Full Text] [Related]
4. Delayed puberty, gonadotropin abnormalities and subfertility in male Padi2/Padi4 double knockout mice. Sams KL; Mukai C; Marks BA; Mittal C; Demeter EA; Nelissen S; Grenier JK; Tate AE; Ahmed F; Coonrod SA Reprod Biol Endocrinol; 2022 Oct; 20(1):150. PubMed ID: 36224627 [TBL] [Abstract][Full Text] [Related]
5. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Knight JS; Subramanian V; O'Dell AA; Yalavarthi S; Zhao W; Smith CK; Hodgin JB; Thompson PR; Kaplan MJ Ann Rheum Dis; 2015 Dec; 74(12):2199-206. PubMed ID: 25104775 [TBL] [Abstract][Full Text] [Related]
6. Protein Deiminase 4 and CR3 Regulate Clark HL; Abbondante S; Minns MS; Greenberg EN; Sun Y; Pearlman E Front Immunol; 2018; 9():1182. PubMed ID: 29896200 [TBL] [Abstract][Full Text] [Related]
7. Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis. Lloyd KA; Wigerblad G; Sahlström P; Garimella MG; Chemin K; Steen J; Titcombe PJ; Marklein B; Zhou D; Stålesen R; Ossipova E; Lundqvist C; Ekwall O; Rönnelid J; Mueller DL; Karlsson MCI; Kaplan MJ; Skriner K; Klareskog L; Wermeling F; Malmström V; Grönwall C Front Immunol; 2018; 9():3033. PubMed ID: 30662440 [TBL] [Abstract][Full Text] [Related]
8. At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases. Barnado A; Crofford LJ; Oates JC J Leukoc Biol; 2016 Feb; 99(2):265-78. PubMed ID: 26658004 [TBL] [Abstract][Full Text] [Related]
9. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets. Curran AM; Naik P; Giles JT; Darrah E Nat Rev Rheumatol; 2020 Jun; 16(6):301-315. PubMed ID: 32341463 [TBL] [Abstract][Full Text] [Related]
10. Macrophage extracellular traps require peptidylarginine deiminase 2 and 4 and are a source of citrullinated antigens bound by rheumatoid arthritis autoantibodies. Bashar SJ; Holmes CL; Shelef MA Front Immunol; 2024; 15():1167362. PubMed ID: 38476240 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of peptidylarginine deiminase alleviates LPS-induced pulmonary dysfunction and improves survival in a mouse model of lethal endotoxemia. Liang Y; Pan B; Alam HB; Deng Q; Wang Y; Chen E; Liu B; Tian Y; Williams AM; Duan X; Wang Y; Zhang J; Li Y Eur J Pharmacol; 2018 Aug; 833():432-440. PubMed ID: 29981294 [TBL] [Abstract][Full Text] [Related]
12. Increased citrullination and expression of peptidylarginine deiminases independently of P. gingivalis and A. actinomycetemcomitans in gingival tissue of patients with periodontitis. Engström M; Eriksson K; Lee L; Hermansson M; Johansson A; Nicholas AP; Gerasimcik N; Lundberg K; Klareskog L; Catrina AI; Yucel-Lindberg T J Transl Med; 2018 Jul; 16(1):214. PubMed ID: 30064459 [TBL] [Abstract][Full Text] [Related]
13. ROLE OF PEPTIDYLARGININE DEIMINASE AND NEUTROPHIL EXTRACELLULAR TRAPS IN INJURIES: FUTURE NOVEL DIAGNOSTICS AND THERAPEUTIC TARGETS. Ho JW; Quan C; Gauger MA; Alam HB; Li Y Shock; 2023 Feb; 59(2):247-255. PubMed ID: 36597759 [TBL] [Abstract][Full Text] [Related]
14. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures. Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274 [TBL] [Abstract][Full Text] [Related]
15. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities. Wood DD; Ackerley CA; Brand Bv; Zhang L; Raijmakers R; Mastronardi FG; Moscarello MA Lab Invest; 2008 Apr; 88(4):354-64. PubMed ID: 18227806 [TBL] [Abstract][Full Text] [Related]
16. Activation of Peptidylarginine Deiminase in the Salivary Glands of Rodríguez-Rodríguez M; Herrera-Esparza R; Bollain Y Goytia JJ; Pérez-Pérez ME; Pacheco-Tovar D; Murillo-Vázquez J; Pacheco-Tovar G; Avalos-Díaz E J Immunol Res; 2017; 2017():8959687. PubMed ID: 29318161 [TBL] [Abstract][Full Text] [Related]
17. Insight into Neutrophil Extracellular Traps through Systematic Evaluation of Citrullination and Peptidylarginine Deiminases. Holmes CL; Shim D; Kernien J; Johnson CJ; Nett JE; Shelef MA J Immunol Res; 2019; 2019():2160192. PubMed ID: 30993117 [TBL] [Abstract][Full Text] [Related]
18. Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice. van Beers JJ; Zendman AJ; Raijmakers R; Stammen-Vogelzangs J; Pruijn GJ Biochimie; 2013 Feb; 95(2):299-308. PubMed ID: 23026755 [TBL] [Abstract][Full Text] [Related]
19. Peptidylarginine deiminase 2 has potential as both a biomarker and therapeutic target of sepsis. Tian Y; Qu S; Alam HB; Williams AM; Wu Z; Deng Q; Pan B; Zhou J; Liu B; Duan X; Ma J; Mondal S; Thompson PR; Stringer KA; Standiford TJ; Li Y JCI Insight; 2020 Oct; 5(20):. PubMed ID: 33055424 [TBL] [Abstract][Full Text] [Related]